Related Experiment Video

Updated: Aug 9, 2026

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

Oncolytic adenoviruses for malignant glioma therapy

Hong Jiang1, Charles Conrad, Juan Fueyo

  • 1Department of Neuro-Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

Frontiers in Bioscience : a Journal and Virtual Library
|April 18, 2003
PubMed

Insights

Oncolytic adenoviruses offer a promising gene therapy approach for malignant gliomas. Strategies focus on improving tumor cell targeting and replication for enhanced anticancer effects, potentially improving patient outcomes.

Area of Science:

  • Oncology
  • Virology
  • Gene Therapy
  • Neuroscience

Background:

  • Malignant gliomas are aggressive brain tumors with poor prognoses despite standard treatments like radiotherapy and chemotherapy.
  • Understanding glioma biology is crucial for developing novel therapeutic strategies, including gene therapy.
  • Oncolytic adenoviruses represent a cutting-edge approach in cancer treatment.

Purpose of the Study:

  • To review current strategies for enhancing oncolytic adenoviruses for glioma treatment.
  • To discuss methods for improving adenoviral infection, tumor-specific replication, and anticancer efficacy.
  • To explore advancements in conditionally replicative adenoviruses, tropism modification, and transcription/transduction systems.

Main Methods:

  • Review of scientific literature on oncolytic adenoviruses and glioma biology.
  • Analysis of strategies for modifying adenoviral infection and replication.
  • Discussion of tropism modifications and transcription/transduction systems for tumor targeting.

Main Results:

  • Several strategies exist to enhance oncolytic adenoviral therapy for gliomas.
  • Conditionally replicative adenoviruses and tropism modifications improve tumor cell specificity.
  • Targeted transcription/transduction systems further restrict viral replication to cancer cells.

Conclusions:

  • Mastery of adenoviral infection and replication mechanisms is key to their use as anticancer agents.
  • Oncolytic adenoviruses hold significant potential for treating brain tumors.
  • Further development may lead to improved survival rates for glioma patients.

More Related Videos

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts11:15

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.